Table 3.
Rheumatic Symptoms According to Matched Coronavirus Disease 2019 (COVID-19) Patients at 12-Month Follow-up and Participants Without COVID-19
| Variable | Matched Non–COVID-19 Participants (n = 1181) | Matched COVID-19 Patients at 12-Month Follow-up Visit (n = 1181) | P Value |
|---|---|---|---|
| Rheumatic symptoms | 89 (8) | 301 (25) | <.001 |
| Joint pain | |||
| Knee | 45 (4) | 166 (14) | <.001 |
| Shoulder | 17 (1) | 59 (5) | <.001 |
| Hand | 8 (1) | 49 (4) | <.001 |
| Elbow | 2 (0) | 21 (2) | <.001 |
| Neck | 11 (1) | 12 (1) | .83 |
| Foot | 4 (0) | 10 (1) | .11 |
| Hip | 3 (0) | 11 (1) | .032 |
| Ankle | 1 (0) | 8 (1) | .013 |
| Wrist | 2 (0) | 4 (0) | .41 |
| Joint swelling | |||
| Knee | 6 (1) | 11 (1) | .22 |
| Shoulder | 1 (0) | 1 (0) | 1.00 |
| Hand | 2 (0) | 8 (1) | .06 |
| Elbow | 1 (0) | 0 (0) | 1.00 |
| Neck | 0 (0) | 0 (0) | |
| Foot | 0 (0) | 5 (0) | .0084 |
| Hip | 0 (0) | 0 (0) | |
| Ankle | 0 (0) | 2 (0) | .10 |
| Wrist | 1 (0) | 2 (0) | .56 |
| Nonrheumatic symptoms | |||
| Tired | 63 (5) | 239 (20) | <.0001 |
| Muscle weak | 22 (2) | 159 (13) | <.0001 |
| Myalgia | 6 (1) | 64 (5) | <.0001 |
| Headache | 34 (3) | 94 (8) | <.0001 |
Data are presented as No. (%). For every severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) survivor, 1 community-dwelling individual without SARS-CoV-2 infection was randomly sampled without replacement, matching age, sex, and comorbidities including cardiovascular disease, chronic respiratory disease, chronic kidney disease, hypertension, and diabetes.
Abbreviation: COVID-19, coronavirus disease 2019.